Skip to main content
. 2016 Jun 9;63(5):619–626. doi: 10.1093/cid/ciw357

Table 1.

Global Changes in Pneumococcal Serotype Diversity Among Children Colonized and Infected With Streptococcus pneumoniae Before, During, and After the Introduction of the 7- and 13-Valent Pneumococcal Conjugate Vaccines

Study, First Author (Year) Country Study Population Age Group Sample Size Simpson's D (95% CI)
Pre-PCV7 Period Early PCV7 Period Late PCV7 Period Post–PCV13 Introduction
Black et al (2007) [13] United States IPD <5 y 519 0.864 (.847–.881) 0.947 (.935–.958) NR NR
Lacapa et al (2008) [14] United States IPD <5 y 59 0.928 (.919–.937) 0.940 (.896–.984) NR NR
Guevara et al (2009) [15] Spain IPD <5 y 78 NR 0.916 (.900–.932) 0.857 (.789–.925) NR
All ages 318 NR 0.923 (.909–.937) 0.882 (.855–.909) NR
Perez-Trallero et al (2009) [16] Spain IPD <5 y 91 0.901 (.878–.924) 0.927 (.902–.953) 0.879 (.804–.954) NR
Kaplan et al (2010) [17] United States IPD <18 y 1030 NR 0.841 (.808–.873) 0.667 (.618–.716) NR
Wenger et al (2010) [18] United States IPD <5 y 384 0.852 (.822–.883) 0.917 (.880–.954) 0.808 (.754–.862) NR
Vestrheim et al (2010) [19] Norway Carriage <5 y 204 0.830 (.790–.871) 0.940 (.922–.958) NR NR
Flasche et al (2011) [20] United Kingdom Carriage <5 y 372 0.891 (.878–.904) 0.960 (.949–.971) NR NR
Richter et al (2013) [21] United States IPD <5 y 243 0.851 (.823–.879) 0.900 (.843–.957) 0.857 (.779–.934) 0.606 (.452–.760)
All ages 1431 0.897 (.885–.908) 0.906 (.886–.927) 0.841 (.810–.873) 0.680 (.630–.729)
Guevara et al (2014) [22] Spain IPD <5 y 207 NR 0.893 (.869–.917) 0.871 (.834–.907) 0.915 (.854–.977)
All ages 688 NR 0.930 (.919–.941) 0.921 (.911–.932) 0.925 (.909–.942)
Moore et al (2014)a [23] United Kingdom IPD <2 y 455 0.868 (.846–.891) 0.927 (.906–.949) 0.946 (.923–.968)
All ages 4850 0.927 (.923–.931) 0.941 (.936–.947) 0.927 (.921–.933)
Richter et al (2014) [24] United States IPD and carriage All ages 3444 NR NR 0.902 (.895–.908) 0.917 (.911–.923)
Moore et al (2015) [12] United States IPD <5 y 2189 NR NR 0.686 (.605–.768) 0.883 (.865–.902)
5–17 y 797 NR NR 0.843 (.802–.884) 0.870 (.845–.896)
Stockmann et al (2016) [35] United States IPD <2 y 266 0.910 (.888–.931) 0.952 (.948–.957) 0.850 (.819–.881) 0.913 (.905–.921)
2–4 y 180 0.928 (.921–.933) 0.935 (.921–.950) 0.877 (.856–.898) 0.908 (.903–.913)
5–17 y 168 0.920 (.900–.939) 0.959 (.874–1.000) 0.872 (.847–.896) 0.906 (.900–.912)
All ages 614 0.920 (.903–.937) 0.949 (.938–.960) 0.867 (.841–.893) 0.921 (.913–.929)

Serotype diversity is expressed as Simpson's D, which measures the probability that 2 pneumococcal isolates selected at random, with replacement, from a given time period will be different serotypes. The value of this index ranges between 0 and 1, with larger values representing greater diversity.

Abbreviations: CI, confidence interval; IPD, invasive pneumococcal disease; NR, not reported; PCV7, 7-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine.

a PCV7 was introduced in September 2006 in the United Kingdom, which was followed by the introduction of PCV13 in April 2010. Moore et al reported their serotype data for the 2006–2010 post-PCV7 period in aggregate, and therefore it was not possible to calculate Simpson's D for the early vs late PCV7 periods.